oligoprogression
Showing 1 - 3 of 3
Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy Trial in Canada (Single fraction SABR, Multiple fraction
Not yet recruiting
- Oligometastatic Disease
- +3 more
- Single fraction SABR
- +3 more
-
Kelowna, British Columbia, Canada
- +4 more
Mar 23, 2023
Brain Metastasis, Oligoprogression Trial in France (Hypofractionated SRT (stereotactic radiotherapy), Historical single-dose SRS
Active, not recruiting
- Brain Metastasis
- Oligoprogression
- Hypofractionated SRT (stereotactic radiotherapy)
- Historical single-dose SRS (stereotactic radiosurgery)
-
Bordeaux, France
- +12 more
Aug 9, 2022
NSCLC, EGFR Positive NSCLC, Oligoprogression Trial in München (Osimertinib, Radiotherapy)
Recruiting
- NSCLC
- +2 more
- Osimertinib
- Radiotherapy
-
München, GermanyLMU Klinikum der Universität München
May 17, 2022